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SENSITIVITY OF AN IMMUNOENZYMATIC TEST FOR THE DETECTION OF ANTI-L. braziliensis
ANTIBODIES COMPARED TO OTHER TESTS USED FOR THE DIAGNOSIS OF AMERICAN
CUTANEOUS LEISHMANIASIS
Maíra Peres FERREIRA(1), Ana Maria Ferreira ROSELINO(2), Margarida Maria Passeri NASCIMENTO(1), Juliana Machado AIRES(2)
& José Fernando de Castro FIGUEIREDO(1)
SUMMARY
The diagnosis of American cutaneous leishmaniasis (ACL) is frequently based on clinical and epidemiological data associated
with the results of laboratory tests. Some laboratory methods are currently being applied for the diagnosis of ACL, among them
the indirect immunofluorescence reaction (IIFR), the Montenegro skin test (MST), histopathological examination, and the polymerase
chain reaction (PCR). The performance of these methods varies in a considerable proportion of patients. After the standardization
of an immunoenzymatic test (ELISA) for the detection of IgG in the serum of patients with ACL using a crude Leishmania
braziliensis antigen, the results obtained were compared to those of other tests routinely used for the diagnosis. The tests revealed
the following sensitivity, when analyzed separately: 85% for ELISA IgG, 81% for PCR, 64.4% for MST, 58.1% for IIFR, and 34%
for the presence of parasites in the biopsy. ELISA was positive in 75% of patients with ACL presenting a negative MST, in 84.8%
of ACL patients with negative skin or mucous biopsies for the presence of the parasite, and in 100% of cases with a negative PCR.
Thus, ELISA presented a higher sensitivity than the other tests and was useful as a complementary method for the diagnosis of
ACL.
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INTRODUCTION
The leishmaniasis are among the most frequent infectious-parasitic
diseases in the world, with an estimated world prevalence of 12 million
patients and an incidence of about 600,000 new cases per year4,10. Over
the last few years, the occurrence of American cutaneous leishmaniasis
(ACL) has been increasing in the Northeast region of the state of São
Paulo and neighboring states. In some regions such as the Vale do
Ribeira, Campinas and Sorocaba, epidemic outbreaks have been
reported, usually linked to soil occupation by new planting areas or to
invasion of the forest by urban expansion2.
A definitive diagnosis of ACL is frequently based on clinical and
epidemiologic data associated with a laboratory diagnosis. The tests
traditionally used for the diagnosis of this disease are the indirect
immunofluorescence reaction (IIFR), the Montenegro skin test (MST),
histopathological examination, and the polymerase chain reaction
(PCR). The standardization of an immunoenzymatic test (ELISA) as
an aid for the diagnosis of ATL is justified since these routinely applied
tests have variable sensitivity.
The objective of the present study was to compare the sensitivity
of an ELISA test using a Leishmania (V.) braziliensis strain as antigen
to the sensitivity of IIFR, MST and PCR in a skin or mucosa biopsy
and to the visualization of parasites in a skin or mucosa biopsy from
patients with ACL attended at the University Hospital of the Faculty
of Medicine of Ribeirão Preto, University of São Paulo.
PATIENTS AND METHODS
The study was approved by the Research Ethics Committee of
HCFMRP/USP (Process HCRP No. 3308/2003) and all subjects gave
written informed consent to participate.
Patients. The study was conducted in the serum of 53 patients
attended at the Infectious Diseases and Dermatology outpatient clinics
of HCFMRP/USP with signs and symptoms compatible with ACL,
associated with positivity to at least one of the following tests: IIFR
for leishmaniasis (titers ≥ 1:40). MST (presence of a papule or nodule
≥ 5 mm in diameter), PCR (using specific primers) in skin or mucous
biopsy, and visualization of the parasites in a skin or mucous biopsy.
The data regarding the results of the tests that were compared to
ELISA were obtained by reviewing the medical records of the patients.
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Immunoenzymatic assay. Leishmania braziliensis promastigotes
(strain 2762) were kept in Schnneider’s Drosophila liquid medium”
(Gibco)3 supplemented with 2% male urine, 20% sterile fetal calf serum
and 1% gentamicin. The parasite pellet, obtained after centrifugation of
the culture medium, was suspended in 0.5 mL sterile distilled water and
submitted to at least 12 cycles of freezing and thawing using liquid
nitrogen and a water bath at 70 °C. After the last cycle, the tubes were
centrifuged and the supernatant containing the antigen preparation was
removed for the quantitation of protein content6. The antigen thus obtained
was stored in a freezer at -70 °C in 1 mL aliquots until the time for use.
A noncompetitive indirect immunoassay method (ELISA)11 was
applied using polystyrene microtiter plates as the solid phase (Immulon
II – Dynatech Laboratories) and peroxidase-conjugated goat anti-human
IgG (Sigma Immuno Chemicals). Hydrogen peroxide (H2O2) and o-
phenylenediamine di-hydrochloride (Sigma) were used as substrate.
The results were reported as the OD/cut-off ratio, with values ≥ 1 being
considered positive.
RESULTS
The sensitivity of the different diagnostic tests applied to patients
with ACL was analyzed separately and was found to be 85% for the
ELISA anti-IgG test in serum, 81% for PCR in a skin or mucous biopsy,
64.4% for MST, 58.1% for IIFR for leishmaniasis, and 34% for the
presence of parasites in the biopsy. These values are illustrated in Fig. 1.
The performance of ELISA compared to the results obtained with
the MST, with the visualization of parasites in a skin and/or mucous
biopsy and with PCR applied to a skin and/or mucous biopsy can be
observed in Fig. 2, 3 and 4.
It can be seen that ELISA was positive in 75% of ATL patients
with a negative MST (Fig. 2). Similarly, the test was positive in 84.8%
of ATL patients with a skin or mucosa biopsy that was negative for the
presence of parasites (Fig. 3) and detected 100% of cases with a negative
PCR applied to a skin or mucous biopsy (Fig. 4).
DISCUSSION
The usefulness of ELISA as an alternative method for the diagnosis
of ACL, was evident since the performance of the test was superior to
Fig. 1 - Sensitivity of each test when used separately in patients with ACL.
Fig. 2 - Values of OD/cut-off of ELISA for the detection of anti-L.braziliensis IgG in the
serum of patients with ACL according to the result of the Montenegro intradermal reaction.
Dotted horizontal line: cut-off = 1.0.
Fig. 3 - Values of OD/cut-off of ELISA for the detection of anti-L.braziliensis IgG in the
serum of patients with ACL according to the presence of the parasite in the biopsy. Dotted
horizontal line: cut-off = 1.0.
Fig. 4 - Values of OD/cut-off of ELISA for the detection of anti-L.braziliensis IgG in the
serum of patients with ACL according to the result of the polymerase chain reaction. Dotted
horizontal line: cut-off = 1.0.
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that of all the other diagnostic tests used. GARCIA4 detected positivities
similar to those reported here but did not report about ELISA. He
observed 81.6% positivity for PCR, 73.4% for MST, 59.7% for IIFR,
and 30.6% for a biopsy. ODDONE et al.8, in a study of the usefulness
of diagnostic tests applied to mucous leishmaniasis, detected 100%
positivity for MST, 88% for PCR, 78.6% for IIFR, 16% for parasite
culture, and 4% for histopathology, but did not use ELISA. In the
evaluation of ELISA using an L. tropica major antigen in patients with
cutaneous leishmaniasis caused by this parasite, ROFFI et al.9 reported
97% positivity for the test. The Health Ministry7 estimates 90%
positivity for MST and 70% for IIFR in ulcerated lesions caused by L.
(V). braziliensis. On the other hand, PCR is not recommended in this
publication as a standardized method for the laboratory diagnosis of
ACL. GONTIJO & CARVALHO5 consider culture to have 50% overall
sensitivity for L. braziliensis infections. In contrast, the micro-ELISA
test showed 100% positivity in patients with a confirmed diagnosis of
cutaneous leishmaniasis with the presence of multiple lesions and in
patients with cutaneous-mucosal leishmaniasis when promastigote
forms of L. braziliensis panamensis were used1.
Thus, the ELISA test presented higher sensitivity in the population
studied compared separately to the other tests and can be considered a
complementary method for the diagnosis of ACL because it identified
a considerable proportion of patients with ACL who presented negative
results in the other diagnostic tests.
RESUMO
Sensibilidade de teste imunoenzimático anti-L. braziliensis em
relação a outros testes utilizados no diagnóstico da leishmaniose
tegumentar americana
O diagnóstico da Leishmaniose Tegumentar Americana (LTA) é
feito com base nos dados clínicos e epidemiológicos e é confirmado
por meio de diferentes métodos laboratoriais. Dentre estes, são
utilizados, com desempenhos variáveis, a reação de imunofluorescência
indireta (IFI), a reação intradérmica de Montenegro (IRM), a pesquisa
de Leishmania em material de biópsia de pele ou mucosa e a reação
em cadeia da polimerase (PCR). O objetivo do presente trabalho foi
avaliar o desempenho de teste imunoenzimático (ELISA) como método
alternativo de diagnóstico da LTA, comparando seus resultados com
os obtidos por outros métodos tradicionais de diagnóstico dessa doença.
Foi utilizado teste para pesquisa de IgG anti-Leishmania no soro,
utilizando antígeno bruto de Leishmania braziliensis, com os seguintes
resultados de sensibilidade: ELISA = 85%; PCR = 81%; IRM = 64.4%;
IFI = 58,1%; presença de parasitas na biópsia = 34%. Além disso, o
teste ELISA foi positivo em parcela expressiva dos pacientes que
apresentavam outros testes diagnósticos negativos (foi positivo em
100% dos pacientes com PCR negativo; em 84,8% dos casos com
biópsias mostrando ausência de parasitas e em 75% dos não reativos a
IRM) mostrando-se útil como método alternativo de diagnóstico da
LTA.
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